Study of the Effect of Differing Platelet Transfusion Times in Neonates
The Effect of Variable Platelet Transfusion Durations on Platelet Count in Thrombocytopenic Newborns
1 other identifier
interventional
21
1 country
1
Brief Summary
To evaluate changes in platelet counts and hemodynamics between "rapid" and "long" platelet infusion groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2009
CompletedFirst Submitted
Initial submission to the registry
July 27, 2009
CompletedFirst Posted
Study publicly available on registry
July 29, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2010
CompletedResults Posted
Study results publicly available
July 12, 2011
CompletedJuly 12, 2011
June 1, 2011
1.6 years
July 27, 2009
February 21, 2011
June 13, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in Post-transfusion Platelet Counts
The difference between the baseline platelet count and the platelet count taken 30 minutes after completion of the transfusion.
Baseline-30 minutes after transfusion
Change in Post-transfusion Platelet Counts
The difference between the baseline platelet count and the platelet count taken 6 hours after completion of the transfusion.
Baseline - 6 hours after transfusion
30 Minute-6 Hour Difference in Platelet Counts
30 minutes - 6 hours after transfusion
Study Arms (2)
Long transfusion group
ACTIVE COMPARATORThis group of thrombocytopenic neonates who (as determined by the attending physician) are in need of a platelet transfusion will receive the transfusion over a period of two hours.
Short transfusion group
EXPERIMENTALThis group of thrombocytopenic neonates who (as determined by the attending physician) are in need of a platelet transfusion will receive the transfusion over a period of 30 minutes.
Interventions
15cc/kg of non-centrifuged, non-refrigerated, leukoreduced, AB-negative pheresis platelets administered over 30 minutes
15cc/kg of non-centrifuged, non-refrigerated, leukoreduced, AB-negative pheresis platelets given over two hours.
Eligibility Criteria
You may qualify if:
- Infants with significant thrombocytopenia requiring a transfusion of platelets.
You may not qualify if:
- Infants requiring extracorporeal membranous oxygenation.
- Infants with congenital heart disease (other than patent foramen ovale or patent ductus arteriosus).
- Babies diagnosed with neonatal alloimmune thrombocytopenia.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Children's Hospital of Oklahoma
Oklahoma City, Oklahoma, 73104, United States
Related Publications (6)
British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the use of platelet transfusions. Br J Haematol. 2003 Jul;122(1):10-23. doi: 10.1046/j.1365-2141.2003.04468.x. No abstract available.
PMID: 12823341BACKGROUNDJosephson CD, Su LL, Christensen RD, Hillyer CD, Castillejo MI, Emory MR, Lin Y, Hume H, Easley K, Poterjoy B, Sola-Visner M. Platelet transfusion practices among neonatologists in the United States and Canada: results of a survey. Pediatrics. 2009 Jan;123(1):278-85. doi: 10.1542/peds.2007-2850.
PMID: 19117893BACKGROUNDMurray NA, Roberts IA. Neonatal transfusion practice. Arch Dis Child Fetal Neonatal Ed. 2004 Mar;89(2):F101-7. doi: 10.1136/adc.2002.019760.
PMID: 14977890BACKGROUNDRoberts I, Murray NA. Neonatal thrombocytopenia: causes and management. Arch Dis Child Fetal Neonatal Ed. 2003 Sep;88(5):F359-64. doi: 10.1136/fn.88.5.f359.
PMID: 12937037BACKGROUNDSola-Visner M, Saxonhouse MA, Brown RE. Neonatal thrombocytopenia: what we do and don't know. Early Hum Dev. 2008 Aug;84(8):499-506. doi: 10.1016/j.earlhumdev.2008.06.004. Epub 2008 Aug 5.
PMID: 18684573BACKGROUNDStrauss RG. How I transfuse red blood cells and platelets to infants with the anemia and thrombocytopenia of prematurity. Transfusion. 2008 Feb;48(2):209-17. doi: 10.1111/j.1537-2995.2007.01592.x. Epub 2008 Jan 7.
PMID: 18194380BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Doug Dannaway
- Organization
- University of Oklahoma Health Sciences Center
Study Officials
- PRINCIPAL INVESTIGATOR
Douglas Dannaway, M.D.
University of Oklahoma
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
July 27, 2009
First Posted
July 29, 2009
Study Start
May 1, 2009
Primary Completion
December 1, 2010
Study Completion
December 1, 2010
Last Updated
July 12, 2011
Results First Posted
July 12, 2011
Record last verified: 2011-06